Protara Therapeutics, Inc. (TARA) Insider Ownership

Historic Insider Ownership Trends

As of March 23, 2026, the three largest insider holders of TARA are Jesse Shefferman (Ceo And President, 1.02Mn shares), Jacqueline Zummo (Chf Scientific Operations Off, 118.56K shares), Leonardo Viana Nicacio (Chief Medical Officer, 78.18K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Jesse Shefferman Ceo And President 1,021,832 0 27 Jan, 2026
Jacqueline Zummo Chf Scientific Operations Off 118,559 0 27 Jan, 2026
Leonardo Viana Nicacio Chief Medical Officer 78,181 0 21 Jan, 2026
William Conkling Chief Commercial Officer 76,000 0 21 Jan, 2026
Patrick Fabbio Chief Financial Officer 64,115 0 27 Jan, 2026
Jathin Bandari Chief Medical Officer 56,704 0 23 Jan, 2024
Richard S Levy 51,000 0 19 May, 2025
Management Inc. Opaleye 0 45,000 12 Sep, 2024
Hannah Fry Vp, Controller 42,723 0 27 Jan, 2026
Blaine Davis Chief Financial Officer 20,662 0 19 Jul, 2022
Martin Sebastian Olivo Chief Medical Officer 14,344 0 14 Jun, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
26 Jan, 2026 Jacqueline Zummo Common Stock D 3,724 $6.67 118,559 D F
26 Jan, 2026 Patrick Fabbio Common Stock D 3,261 $6.67 64,115 D F
26 Jan, 2026 Jesse Shefferman Common Stock D 8,732 $6.67 1,021,832 D F
26 Jan, 2026 Hannah Fry Common Stock D 1,457 $6.67 42,723 D F
20 Jan, 2026 Hannah Fry Common Stock D 2,132 $5.60 44,180 D F
20 Jan, 2026 Jacqueline Zummo Common Stock D 6,578 $5.60 122,283 D F
20 Jan, 2026 Patrick Fabbio Common Stock D 3,063 $5.60 67,376 D F
20 Jan, 2026 Jesse Shefferman Common Stock D 16,322 $5.60 1,030,564 D F
16 Jan, 2026 Hannah Fry Common Stock A 9,500 $0.00 46,312 D A
16 Jan, 2026 Jesse Shefferman Common Stock A 87,000 $0.00 1,046,886 D A
16 Jan, 2026 William Conkling Common Stock A 26,000 $0.00 76,000 D A
16 Jan, 2026 Leonardo Viana Nicacio Common Stock A 26,000 $0.00 78,181 D A
16 Jan, 2026 Jacqueline Zummo Common Stock A 30,000 $0.00 128,861 D A
16 Jan, 2026 Patrick Fabbio Common Stock A 28,000 $0.00 70,439 D A
16 Jan, 2026 Patrick Fabbio Stock Option (Right to Buy) A 175,000 $0.00 175,000 D A
16 Jan, 2026 Jacqueline Zummo Stock Option (Right to Buy) A 180,000 $0.00 180,000 D A
16 Jan, 2026 Leonardo Viana Nicacio Stock Option (Right to Buy) A 158,000 $0.00 158,000 D A
16 Jan, 2026 Jesse Shefferman Stock Option (Right to Buy) A 524,000 $0.00 524,000 D A
16 Jan, 2026 William Conkling Stock Option (Right to Buy) A 158,000 $0.00 158,000 D A
16 Jan, 2026 Hannah Fry Stock Option (Right to Buy) A 55,000 $0.00 55,000 D A